Ani Pharmaceuticals (ANIP) Long-Term Investments (2010 - 2013)

Ani Pharmaceuticals (ANIP) has 4 years of Long-Term Investments data on file, last reported at $3.4 million in Q1 2013.

• For the quarter ending Q1 2013, Long-Term Investments changed 0.0% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2013 stood at $3.4 million (changed 0.0% YoY), and the FY2012 full-year result was $3.4 million, changed 0.23% from the prior year.
• Long-Term Investments held at $3.4 million in Q1 2013, from $3.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $3.4 million in Q1 2012 to a low of $3.4 million in Q4 2010.
• A 4-year average of $3.4 million and a median of $3.4 million in 2012 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments changed 0.0% in 2011 and gained 0.23% in 2012, its largest moves.
• Tracing ANIP's Long-Term Investments over 4 years: stood at $3.4 million in 2010, then changed by 0.0% to $3.4 million in 2011, then grew by 0.23% to $3.4 million in 2012, then changed by 0.0% to $3.4 million in 2013.
• Business Quant data shows ANIP's Long-Term Investments at $3.4 million in Q1 2013, $3.4 million in Q4 2012, and $3.4 million in Q3 2012.